Detalles de la búsqueda
1.
Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors.
J Natl Compr Canc Netw
; 21(2): 153-162.e2, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791754
2.
Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
JAMA
; 320(2): 167-176, 2018 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29998338
3.
Hormone receptor status does not affect prognosis in metaplastic breast cancer: a population-based analysis with comparison to infiltrating ductal and lobular carcinomas.
Ann Surg Oncol
; 21(11): 3497-503, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24838367
4.
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial.
J Clin Oncol
; 39(21): 2367-2374, 2021 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33739848
5.
The impact of obesity on treatment choices and outcomes in operable breast cancer.
Am J Surg
; 217(3): 474-477, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30573156
6.
Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers.
Oncotarget
; 7(43): 69903-69915, 2016 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27655711
7.
Measuring the impact of the American College of Surgeons Oncology Group Z0011 trial on breast cancer surgery in a community health system.
Am J Surg
; 209(2): 240-5, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25236187
8.
Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors.
J Clin Oncol
; 31(26): 3233-41, 2013 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23940231
9.
MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance.
Mol Cancer Res
; 11(9): 1112-21, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23825050
10.
Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
Clin Breast Cancer
; 11(4): 228-34, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21684812
11.
Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer.
Mol Cancer Ther
; 9(8): 2423-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20682649
Resultados
1 -
11
de 11
1
Próxima >
>>